Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (Details 2)

v3.21.1
STOCKHOLDERS EQUITY (Details 2)
12 Months Ended
Dec. 31, 2020
$ / shares
shares
Stockholders Equity Abstract  
Range of Exercise price | $ / shares $ 1.19
Options outstanding | shares 500,000
Weighted average exercise price | $ / shares $ 1.19
Weighted Average Remaining Life in Years 1 year 10 months 2 days
Options exercisable | shares 500,000